selected publications
-
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial.
JAMA oncology.
2020
Academic Article
GET IT
Times cited: 131 -
PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence.
Oncogene.
2018
Academic Article
GET IT
Times cited: 33 -
ATRX is a regulator of therapy induced senescence in human cells.
Nature communications.
2017
Academic Article
GET IT
Times cited: 56 -
Multimodality Management of Soft Tissue Tumors in the Extremity.
The Surgical clinics of North America.
2016
Information Resource
GET IT
Times cited: 9 -
Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma.
Cancer discovery.
2016
Academic Article
GET IT
Times cited: 66 -
Liposarcoma: Multimodality Management and Future Targeted Therapies.
Surgical oncology clinics of North America.
2016
Information Resource
GET IT
Times cited: 106 -
Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma.
Sarcoma.
2016
Academic Article
GET IT
Times cited: 10 -
The importance of surgical margins in retroperitoneal sarcoma.
Journal of surgical oncology.
2015
Information Resource
GET IT
Times cited: 28 -
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas.
The oncologist.
2015
Academic Article
GET IT
Times cited: 23 -
Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.
Genes, chromosomes & cancer.
2015
Academic Article
GET IT
Times cited: 139 -
Outcomes of Systemic Therapy for Patients with Metastatic Angiosarcoma.
Oncology.
2015
Academic Article
GET IT
Times cited: 44 -
Principles in Management of Soft Tissue Sarcoma.
Advances in surgery.
2015
Information Resource
GET IT
Times cited: 49 -
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition.
Oncotarget.
2015
Academic Article
GET IT
Times cited: 104 -
Soft tissue tumors of the trunk: management of local disease in the breast and chest and abdominal walls.
Journal of surgical oncology.
2014
Information Resource
GET IT
Times cited: 15 -
Extended surgical resection and histology in retroperitoneal sarcoma.
Annals of surgical oncology.
2014
Editorial Article
GET IT
Times cited: 18 -
Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2014
Academic Article
GET IT
Times cited: 113 -
Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets.
Science signaling.
2013
Academic Article
GET IT
Times cited: 76 -
A prognostic nomogram for prediction of recurrence in desmoid fibromatosis.
Annals of surgery.
2013
Academic Article
GET IT
Times cited: 207 -
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2013
Academic Article
GET IT
Times cited: 360 -
Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors.
Nature genetics.
2013
Academic Article
GET IT
Times cited: 470 -
Desmoid fibromatosis in children and adolescents: a conservative approach to management.
Journal of pediatric surgery.
2013
Academic Article
GET IT
Times cited: 20 -
Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.
Annals of surgical oncology.
2012
Academic Article
GET IT
Times cited: 106 -
The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification.
Genes, chromosomes & cancer.
2012
Academic Article
GET IT
Times cited: 89 -
Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2012
Academic Article
GET IT
Times cited: 61 -
Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma.
Current opinion in oncology.
2011
Information Resource
GET IT
Times cited: 202 -
Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma.
Cancer research.
2011
Academic Article
GET IT
Times cited: 104 -
ZIC1 overexpression is oncogenic in liposarcoma.
Cancer research.
2010
Academic Article
GET IT
Times cited: 41 -
Randomized clinical trials in breast cancer.
Surgical oncology clinics of North America.
2010
Information Resource
GET IT
Times cited: 7 -
Binding of extracellular matrix laminin to Escherichia coli expressing the Salmonella outer membrane proteins Rck and PagC.
FEMS microbiology letters.
1999
Academic Article
GET IT
Times cited: 29 -
Salmonella InvG forms a ring-like multimer that requires the InvH lipoprotein for outer membrane localization.
Molecular microbiology.
1998
Academic Article
GET IT
Times cited: 135 -
Monocyte chemoattractant activity of Ser195-->Ala active site mutant recombinant alpha-thrombin.
Experimental cell research.
1995
Academic Article
GET IT
Times cited: 20